Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yangxindingji capsule is a Traditional Chinese Medicine (TCM) preparation developed by The First Affiliated Hospital of Henan University of Traditional Chinese Medicine. It is primarily indicated for the treatment of premature ventricular contractions (PVCs), bradyarrhythmia, and palpitations associated with qi and blood deficiency. The formula is designed to nourish the heart and stabilize heart rhythm. In clinical studies, it has been evaluated both as a monotherapy and in combination with other TCM treatments like Shengmai Yin to reduce arrhythmia burden, improve heart rate, and alleviate symptoms such as sleep quality issues, anxiety, and depression related to cardiac conditions. As a hospital preparation in China, it represents a specialized botanical approach to managing cardiac rhythm disorders within the framework of integrative medicine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yangxindingji capsule.